Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jul 2010 - 26 pages - $99
Jun 2006 - 434 pages - $2,495
Jul 2011 - 96 pages - $3,835
Dec 2007 - 49 pages - $495
Apr 2010 - 32 pages - $125
Sep 2011 - 79 pages - $3,500
Nov 2009 - 142 pages - $2,350
Feb 2006 - 332 pages - $3,900
Mar 2011 - 47 pages - $125
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us